Delfi Diagnostics: Michaela Hart, Paul Sheives

Delfi Diagnostics has added two new leaders to its management team to oversee regulatory, policy, and reimbursement activities as the company advances its products toward commercialization. Michaela Hart has joined as Delfi's Vice President of regulatory, quality and lab operations, and Paul Sheives has joined as VP of government relations and reimbursement.

Before joining Delfi, Hart was VP of quality systems and compliance for Roche Molecular Solutions. Prior to that, she served as VP of quality management and regulatory affairs for Roche Sequencing USA, and as VP of molecular operations and quality assurance for Veracyte. Sheives joined Delfi in late 2021 and most recently served as senior director of health policy and reimbursement for Roche Diagnostics. He previously held leadership roles at the American Clinical Laboratory Association and the Biotechnology Innovation Organization.